Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: E9B6Z1
Term | Name | Level | Count |
---|---|---|---|
GO:0006468 | protein phosphorylation | 5 | 11 |
GO:0006793 | phosphorus metabolic process | 3 | 11 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016310 | phosphorylation | 5 | 11 |
GO:0019538 | protein metabolic process | 3 | 11 |
GO:0036211 | protein modification process | 4 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0043412 | macromolecule modification | 4 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 11 |
GO:0003824 | catalytic activity | 1 | 11 |
GO:0004672 | protein kinase activity | 3 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0005524 | ATP binding | 5 | 11 |
GO:0016301 | kinase activity | 4 | 11 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 11 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 11 |
GO:0017076 | purine nucleotide binding | 4 | 11 |
GO:0030554 | adenyl nucleotide binding | 5 | 11 |
GO:0032553 | ribonucleotide binding | 3 | 11 |
GO:0032555 | purine ribonucleotide binding | 4 | 11 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 11 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 11 |
GO:0036094 | small molecule binding | 2 | 11 |
GO:0043167 | ion binding | 2 | 11 |
GO:0043168 | anion binding | 3 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:0097367 | carbohydrate derivative binding | 2 | 11 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 11 |
GO:1901265 | nucleoside phosphate binding | 3 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 284 | 288 | PF00656 | 0.759 |
CLV_NRD_NRD_1 | 23 | 25 | PF00675 | 0.549 |
CLV_PCSK_KEX2_1 | 23 | 25 | PF00082 | 0.560 |
CLV_PCSK_SKI1_1 | 237 | 241 | PF00082 | 0.423 |
CLV_Separin_Metazoa | 169 | 173 | PF03568 | 0.366 |
DEG_APCC_DBOX_1 | 236 | 244 | PF00400 | 0.423 |
DOC_CKS1_1 | 64 | 69 | PF01111 | 0.464 |
DOC_CYCLIN_RxL_1 | 231 | 242 | PF00134 | 0.339 |
DOC_CYCLIN_yCln2_LP_2 | 244 | 250 | PF00134 | 0.332 |
DOC_MAPK_JIP1_4 | 237 | 243 | PF00069 | 0.456 |
DOC_PP4_FxxP_1 | 225 | 228 | PF00568 | 0.423 |
DOC_WW_Pin1_4 | 209 | 214 | PF00397 | 0.311 |
DOC_WW_Pin1_4 | 5 | 10 | PF00397 | 0.692 |
DOC_WW_Pin1_4 | 63 | 68 | PF00397 | 0.392 |
LIG_14-3-3_CanoR_1 | 24 | 32 | PF00244 | 0.536 |
LIG_FHA_1 | 1 | 7 | PF00498 | 0.565 |
LIG_FHA_1 | 148 | 154 | PF00498 | 0.411 |
LIG_FHA_1 | 20 | 26 | PF00498 | 0.516 |
LIG_FHA_1 | 200 | 206 | PF00498 | 0.295 |
LIG_FHA_1 | 59 | 65 | PF00498 | 0.509 |
LIG_Integrin_RGD_1 | 172 | 174 | PF01839 | 0.456 |
LIG_LIR_Apic_2 | 224 | 228 | PF02991 | 0.389 |
LIG_LIR_Apic_2 | 90 | 95 | PF02991 | 0.287 |
LIG_LIR_Gen_1 | 66 | 74 | PF02991 | 0.400 |
LIG_LIR_Nem_3 | 66 | 72 | PF02991 | 0.398 |
LIG_LIR_Nem_3 | 86 | 92 | PF02991 | 0.319 |
LIG_NRBOX | 184 | 190 | PF00104 | 0.423 |
LIG_SH2_CRK | 155 | 159 | PF00017 | 0.475 |
LIG_SH2_CRK | 92 | 96 | PF00017 | 0.467 |
LIG_SH2_STAT5 | 69 | 72 | PF00017 | 0.382 |
LIG_SH3_3 | 6 | 12 | PF00018 | 0.761 |
LIG_SH3_3 | 61 | 67 | PF00018 | 0.496 |
LIG_SUMO_SIM_par_1 | 237 | 242 | PF11976 | 0.339 |
LIG_TYR_ITIM | 153 | 158 | PF00017 | 0.475 |
LIG_UBA3_1 | 189 | 198 | PF00899 | 0.265 |
MOD_CK1_1 | 19 | 25 | PF00069 | 0.446 |
MOD_CK1_1 | 196 | 202 | PF00069 | 0.274 |
MOD_CK1_1 | 221 | 227 | PF00069 | 0.315 |
MOD_CK1_1 | 266 | 272 | PF00069 | 0.672 |
MOD_CK1_1 | 273 | 279 | PF00069 | 0.755 |
MOD_CK2_1 | 200 | 206 | PF00069 | 0.164 |
MOD_CK2_1 | 273 | 279 | PF00069 | 0.712 |
MOD_CK2_1 | 30 | 36 | PF00069 | 0.497 |
MOD_GlcNHglycan | 18 | 21 | PF01048 | 0.418 |
MOD_GlcNHglycan | 195 | 198 | PF01048 | 0.261 |
MOD_GlcNHglycan | 220 | 223 | PF01048 | 0.349 |
MOD_GlcNHglycan | 250 | 253 | PF01048 | 0.536 |
MOD_GlcNHglycan | 92 | 95 | PF01048 | 0.544 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.684 |
MOD_GSK3_1 | 196 | 203 | PF00069 | 0.359 |
MOD_GSK3_1 | 205 | 212 | PF00069 | 0.337 |
MOD_GSK3_1 | 214 | 221 | PF00069 | 0.264 |
MOD_GSK3_1 | 263 | 270 | PF00069 | 0.696 |
MOD_GSK3_1 | 281 | 288 | PF00069 | 0.743 |
MOD_GSK3_1 | 31 | 38 | PF00069 | 0.354 |
MOD_N-GLC_1 | 273 | 278 | PF02516 | 0.731 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.495 |
MOD_NEK2_1 | 193 | 198 | PF00069 | 0.439 |
MOD_NEK2_1 | 214 | 219 | PF00069 | 0.370 |
MOD_NEK2_1 | 248 | 253 | PF00069 | 0.469 |
MOD_NEK2_1 | 35 | 40 | PF00069 | 0.500 |
MOD_PKA_2 | 25 | 31 | PF00069 | 0.518 |
MOD_Plk_1 | 74 | 80 | PF00069 | 0.451 |
MOD_Plk_2-3 | 267 | 273 | PF00069 | 0.659 |
MOD_Plk_4 | 221 | 227 | PF00069 | 0.334 |
MOD_ProDKin_1 | 209 | 215 | PF00069 | 0.311 |
MOD_ProDKin_1 | 5 | 11 | PF00069 | 0.692 |
MOD_ProDKin_1 | 63 | 69 | PF00069 | 0.390 |
TRG_DiLeu_BaEn_1 | 206 | 211 | PF01217 | 0.330 |
TRG_DiLeu_BaLyEn_6 | 235 | 240 | PF01217 | 0.400 |
TRG_ENDOCYTIC_2 | 155 | 158 | PF00928 | 0.487 |
TRG_ENDOCYTIC_2 | 69 | 72 | PF00928 | 0.386 |
TRG_ER_diArg_1 | 23 | 26 | PF00400 | 0.556 |
TRG_ER_diArg_1 | 39 | 42 | PF00400 | 0.314 |
TRG_ER_diArg_1 | 45 | 48 | PF00400 | 0.505 |
TRG_Pf-PMV_PEXEL_1 | 237 | 242 | PF00026 | 0.456 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IAR1 | Leptomonas seymouri | 59% | 98% |
A0A1X0P5S2 | Trypanosomatidae | 34% | 100% |
A0A3Q8IFJ8 | Leishmania donovani | 90% | 100% |
A0A422P1C1 | Trypanosoma rangeli | 32% | 100% |
A4HNC9 | Leishmania braziliensis | 79% | 100% |
C9ZYK5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 100% |
E9AFT9 | Leishmania major | 91% | 100% |
E9AHW8 | Leishmania infantum | 90% | 100% |
O70150 | Rattus norvegicus | 29% | 84% |
Q6P2M8 | Homo sapiens | 29% | 84% |
Q8BW96 | Mus musculus | 24% | 75% |
Q8IU85 | Homo sapiens | 24% | 75% |
Q9QYK9 | Mus musculus | 29% | 84% |
V5C2I6 | Trypanosoma cruzi | 33% | 100% |